What is the maximum daily dose for intravenous (IV) Amoxicillin (Amoxicillin)/Clavulanic acid (Clavulanic acid) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The maximum daily dose of intravenous amoxicillin/clavulanic acid for pediatric patients is 200 mg/kg/day of the amoxicillin component, not to exceed 6 grams per day, as supported by the most recent and highest quality evidence available 1.

Key Considerations

  • Dosing is based on the amoxicillin component, with the clavulanic acid component following in a fixed ratio.
  • Weight-based dosing is essential in pediatrics to ensure adequate drug concentrations while avoiding toxicity.
  • Renal function should be assessed before administration, as dose adjustments are necessary for patients with impaired kidney function.
  • The medication should be administered slowly over 30 minutes to reduce the risk of vein irritation.
  • Monitoring for adverse effects such as rash, diarrhea, and signs of allergic reaction is important during treatment.

Rationale

The dosing of amoxicillin/clavulanic acid in pediatric patients is critical to ensure effective treatment of infections while minimizing the risk of adverse effects. The recommended maximum daily dose is based on the amoxicillin component, which is the primary active ingredient in the combination. The clavulanic acid component is added to enhance the spectrum of activity against beta-lactamase-producing organisms.

Administration and Monitoring

  • The medication should be administered intravenously, slowly over 30 minutes, to reduce the risk of vein irritation.
  • Monitoring for adverse effects such as rash, diarrhea, and signs of allergic reaction is crucial during treatment.
  • Renal function should be assessed before administration, and dose adjustments made as necessary for patients with impaired kidney function.

Evidence Base

The recommendation is based on the most recent and highest quality evidence available, including a narrative review of the properties and use of oral amoxicillin and clavulanic acid 1. While this review focuses on oral formulations, the principles of dosing and administration can be applied to intravenous use in pediatric patients.

Clinical Considerations

  • For severe infections, the higher end of the dosing range should be used.
  • Dosing should be individualized based on the patient's weight, renal function, and severity of infection.
  • Close monitoring of the patient's response to treatment and adjustment of the dose as needed is essential to ensure effective treatment and minimize the risk of adverse effects.

References

Research

Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.